Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. The company was founded by Robert Axtell, Guy Cavet, Jeremy Sokolove, Tito A. Serafini, Paulette A. Dillon, Daniel Emerling, Wayne Volkmuth, Jonathan Woo, Yann Chong Tan, William H. Robinson and Lawrence J. Steinman on June 11, 2010 and is headquartered in San Carlos, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Atreca Inc - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Atreca Inc - Ordinary Shares - Class A market cap is $3.17M.
What is the 52-week high for Atreca Inc - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Atreca Inc - Ordinary Shares - Class A 52 week high is $1.26 as of September 09, 2025.
What is the 52-week low for Atreca Inc - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Atreca Inc - Ordinary Shares - Class A 52 week low is $0.052 as of September 09, 2025.
What is Atreca Inc - Ordinary Shares - Class A stock price today?
Atreca Inc - Ordinary Shares - Class A stock price today is $0.088.
What was Atreca Inc - Ordinary Shares - Class A stock price yesterday?
Atreca Inc - Ordinary Shares - Class A stock price yesterday was $0.08.
What is the PE ratio of Atreca Inc - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Atreca Inc - Ordinary Shares - Class A’s P/E ratio is -0.03.
What is the Price-to-Book ratio of Atreca Inc - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Atreca Inc - Ordinary Shares - Class A P/B ratio is 0.2946.
What is Atreca Inc - Ordinary Shares - Class A's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Atreca Inc - Ordinary Shares - Class A's EBITDA is 0.15.
What is the 50-day moving average of Atreca Inc - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Atreca Inc - Ordinary Shares - Class A 50-day moving average is $0.1531.
